All News

New drugs, new generics, new OTC

Let this be the year you do something for the cause.

Letters, e-mails, posts, and comments from readers of Drug Topics

That’s the assertion a Philadelphia-area pharmacist is making in a federal class action suit filed recently at the U.S. District Court for the Eastern District of Pennsylvania.

The factor Xa inhibitor edoxaban (Savaysa, Daiichi Sankyo) has been approved by FDA to lower the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), according to a January 8 announcement.

Prosecutors seized $18 million from accounts linked to the owners of the defunct New England Compounding Center, whose tainted products led to the 2012 meningitis outbreak that killed at least 64 people and sickened about 750.

Gloria E. Meredith was recently named founding dean of Binghamton University’s School of Pharmacy and Pharmaceutical Sciences in New York.

Looking back, what do you think was missing from your pharmacy education? And what should a 21st century curriculum include?

The U.S. Centers for Disease Control and Prevention and the American Pharmacists Association Foundation recently announced a partnership intended to integrate pharmacy into public health efforts to manage hypertension.

A pharmacy-led prior authorization service can generate additional hospital revenues through increased reimbursements and decreased write-offs, according to a case study to be published in the American Journal of Health-System Pharmacy.

Several state agencies here are combining resources to create strategies to prevent deaths and injuries from prescription-painkiller overdoses.

In an effort to curb prescription drug overdoses and short circuit pill-mills, Florida banned physician dispensing of strong opioids back in 2011.

According to the most recent update from the U.S. Centers for Disease Control and Prevention (CDC), 15 children in the United States have died thus far this flu season as influenza has reached epidemic levels.

Agency kicks medical product safety-monitoring into a higher gear.

The American Diabetes Association (ADA) is calling for all patients with diabetes who are at high risk for cardiovascular disease (CVD) to be treated with statins and lifestyle therapy, according to its recently published guidance in the January issue of Diabetes Care.

How is it that entire clans can get hooked on the profession of pharmacy? This time, we read about a family in North Carolina that was bitten by the bug.

The Centers for Medicare and Medicaid Services (CMS) recently informed Louisiana that it’s been using an improper reimbursement formula to pay pharmacists through its state Medicaid program.

Agents from the Drug Enforcement Administration recently searched records at a Virginia hospital pharmacy in connection with stolen narcotics with an estimated street value close to $1.4 million.

A Walgreens store in Ferguson, Mo., which was damaged during the protests over the Michael Brown case, reopened right before Christmas.

During one six-month period, one West Virginia doctor wrote prescriptions linked to six drug-overdose deaths; nine other doctors wrote prescriptions linked to two or more overdose deaths.

A judge has reinstated the pharmacy license of a former Rhode Island state senator who mistakenly gave morphine to an infant and a toddler.

Even as cynicism grows about the pharmaceutical industry, Americans continue to view pharmacists as among the most honest and ethical professionals.

David Webster, associate director of pharmacy operations, University of Rochester Medical Center (URMC), explains URMC’s decision to transition to in-sourced IV compounding.

What stories got the most attention from Drug Topics readers in 2014? Here are the top 10.

Pharmacists and other healthcare professionals have more work to do before consumers understand the dangers of misusing acetaminophen.

Between 2010 and 2013, a significant decline in medical errors at U.S. hospitals reduced hospital-acquired conditions, saving an estimated 50,000 lives and billions of dollars.

Ohio legislators have approved a bill that would shield the identities of pharmacies and pharmacists that compound lethal injection drugs used in executions.

The committee is comprised of 14 members-12 voting and two non-voting-who will provide advice on scientific, technical, and medical issues concerning drug compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.